New hope for lymphoma patients: mosunetuzumab under review
NCT ID NCT07278921
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at medical records of 25 adults with follicular lymphoma that returned or didn't respond to at least two prior treatments. All patients received mosunetuzumab through a compassionate use program. Researchers want to see how well the drug works and what side effects occur.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mosunetuzumab
What this could lead to
If successful, this could provide a treatment option for patients with follicular lymphoma who have not responded to other therapies.
What could go wrong
This is a small, retrospective observational study, not a controlled trial. Results may not apply to all patients, and there are risks like infusion reactions and nervous system side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Ospedale San Raffaele
RECRUITINGMilan, 20132, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••